KRAS and transitional cell carcinoma: For generating basal-like UBC, we, thus, favored the combination of a Trp53 knockout with the plasmid combination of added Kras and Cmyc and using an epithelium-specific promoter like KRT14. We favored this combination due to the faster tumor take and the higher rate of urothelial cell carcinomas.